Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing, China.
Department of Biotechnology, School of Life Science, Chongqing University, Chongqing, China.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019 Sep;11(5):e1555. doi: 10.1002/wnan.1555. Epub 2019 Apr 23.
Increasing research evidence reveals that cancer is complex disease involving many biological factors, processes and systems, which may severely limit the actual efficacy of conventional monotonic anticancer approaches. To overcome these obstacles in cancer treatment, a new strategy has been proposed by combining multiple synergistic therapeutic modalities accessing different but inherently related targets and acting sequentially. A major benefit of this strategy is that the multi-target mechanism could result in a cascade-amplification effect leading to enhanced anticancer activity. In this review, we provide a critical discussion on the application of cascade-amplification strategy in the treatment of various cancer indications, focusing on the rational combination of therapeutic agents and their mechanisms of action. A concise yet comprehensive analysis on the potential therapeutic benefit of this strategy was also included. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease.
越来越多的研究证据表明,癌症是一种复杂的疾病,涉及许多生物因素、过程和系统,这可能严重限制传统的单一抗癌方法的实际疗效。为了克服癌症治疗中的这些障碍,已经提出了一种新的策略,即将多种协同治疗模式结合起来,针对不同但内在相关的靶点,并依次作用。这种策略的一个主要好处是,多靶点机制可能导致级联放大效应,从而增强抗癌活性。在这篇综述中,我们对级联放大策略在治疗各种癌症适应症中的应用进行了批判性讨论,重点讨论了治疗剂的合理组合及其作用机制。还对该策略的潜在治疗益处进行了简明而全面的分析。本文属于以下类别:治疗方法和药物发现 > 肿瘤疾病的纳米医学。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019-4-23
Curr Cancer Drug Targets. 2012-10
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020-9
Adv Healthc Mater. 2017-12-28
Int J Mol Sci. 2021-5-27
J Immunol Res. 2020